Jane Street
CUE icon

Jane Street’s Cue Biopharma CUE Stock Holding History

Jane Street’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,326
Closed -$21.3K – 11787
2025
Q4 		$21.3K Buy
+2,326
New +$42.7K ﹤0.01% 10713
2025
Q1 		– Sell
-2,126
Closed -$69.5K – 9595
2024
Q4 		$69.5K Buy
2,126
+1,261
+146% +$47.4K ﹤0.01% 8880
2024
Q3 		$19.6K Sell
865
-2,422
-74% -$52.5K ﹤0.01% 9297
2024
Q2 		$122K Buy
+3,287
New +$163K ﹤0.01% 8653
2024
Q1 		– Sell
-1,821
Closed -$144K – 9321
2023
Q4 		$144K Buy
+1,821
New +$130K ﹤0.01% 8414
2023
Q2 		– Sell
-899
Closed -$96.3K – 8801
2023
Q1 		$96.3K Buy
+899
New +$85.7K ﹤0.01% 8246
2020
Q3 		– Sell
-419
Closed -$308K – 7230
2020
Q2 		$308K Buy
+419
New +$304K ﹤0.01% 5795

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Jane Street's CUE Position: Q1 2026 in Review

Jane Street sold out of Cue Biopharma (CUE) in Q1 2026, closing a stake of 2,326 shares — an estimated $21.3K sold.

Jane Street first reported a position in CUE in Q2 2020 and held it in 7 quarters. The position peaked at $308K in Q2 2020. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Jane Street reported no remaining Cue Biopharma position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 2,326 Cue Biopharma shares in Q1 2026, an estimated $21.3K.
  • Jane Street first reported a position in Cue Biopharma in Q2 2020 and held it in 7 quarters.
  • Jane Street's Cue Biopharma position peaked at $308K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.